2.22 Safety, Efficacy, and Exposure-Response of Nnz-2591, a Synthetic Analog of Cyclic Glycine-Proline (cGP), an IGF-1 Metabolite, for the Treatment of Phelan-Mcdermid Syndrome in Children and Adolescents